Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinyi Yang

Showing results (511-520 of 549) with videos related to

Pageof 55
Sort By:
Emerging Microbes & Infections|October 26, 2022
FBXO34 promotes latent HIV-1 activation by post-transcriptional modulationXinyi Yang, Xiaying Zhao, Yuqi Zhu, et al.
Virologica Sinica|January 19, 2023
Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env<sup>+</sup> cells invivoHanyu Pan, Xinyi Yang, Jing Wang, et al.
Infectious Diseases of Poverty|September 6, 2022
Optimization of COVID-19 prevention and control measures during the Beijing 2022 Winter Olympics: a model-based studyLingcai Kong, Mengwei Duan, Jin Shi, et al.
Theranostics|September 13, 2024
EBV-associated epithelial cancers cells promote vasculogenic mimicry formation via a secretory cross-talk with the immune microenvironmentTong Xiang, Fengze Sun, Tingting Liu, et al.
Frontiers in Microbiology|July 23, 2021
HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy <i>in vivo</i>Zhengtao Jiang, Huitong Liang, Hanyu Pan, et al.
ACS Nano|May 21, 2026
Silk Fibroin Ionotronics for High-Performance Wearable Perovskite LEDsJiawei Hong, Zhongkai Yu, Weidong Tang, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2023
First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjectsZhiwei Huang, Xinyi Yang, Yi Jin, et al.
Molecules (Basel, Switzerland)|June 12, 2026
Preparation, Oral SNEDDS Formulation, and In Vivo Evaluation of the HIV-1 Latency-Reversing Agent EK-16ALu Jin, Yuqi Zhu, Fan Yang, et al.
EMBO Reports|September 14, 2020
PEBP1 suppresses HIV transcription and induces latency by inactivating MAPK/NF-κB signalingXinyi Yang, Yanan Wang, Panpan Lu, et al.
Journal for Immunotherapy of Cancer|June 17, 2024
EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretionYuanyuan Chen, Dijun Ouyang, Yan Wang, et al.
Pageof 55

Showing results (511-520 of 549) with videos related to

Sort By:
Pageof 55
Emerging Microbes & Infections|October 26, 2022
FBXO34 promotes latent HIV-1 activation by post-transcriptional modulationXinyi Yang, Xiaying Zhao, Yuqi Zhu, et al.
Virologica Sinica|January 19, 2023
Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env<sup>+</sup> cells invivoHanyu Pan, Xinyi Yang, Jing Wang, et al.
Infectious Diseases of Poverty|September 6, 2022
Optimization of COVID-19 prevention and control measures during the Beijing 2022 Winter Olympics: a model-based studyLingcai Kong, Mengwei Duan, Jin Shi, et al.
Theranostics|September 13, 2024
EBV-associated epithelial cancers cells promote vasculogenic mimicry formation via a secretory cross-talk with the immune microenvironmentTong Xiang, Fengze Sun, Tingting Liu, et al.
Frontiers in Microbiology|July 23, 2021
HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy <i>in vivo</i>Zhengtao Jiang, Huitong Liang, Hanyu Pan, et al.
ACS Nano|May 21, 2026
Silk Fibroin Ionotronics for High-Performance Wearable Perovskite LEDsJiawei Hong, Zhongkai Yu, Weidong Tang, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2023
First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjectsZhiwei Huang, Xinyi Yang, Yi Jin, et al.
Molecules (Basel, Switzerland)|June 12, 2026
Preparation, Oral SNEDDS Formulation, and In Vivo Evaluation of the HIV-1 Latency-Reversing Agent EK-16ALu Jin, Yuqi Zhu, Fan Yang, et al.
EMBO Reports|September 14, 2020
PEBP1 suppresses HIV transcription and induces latency by inactivating MAPK/NF-κB signalingXinyi Yang, Yanan Wang, Panpan Lu, et al.
Journal for Immunotherapy of Cancer|June 17, 2024
EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretionYuanyuan Chen, Dijun Ouyang, Yan Wang, et al.
Pageof 55